收藏切换
Analysis and prediction of IBD disease burden in China, 1990-2021
收藏切换
PDF
Hui-min LIU, Jing WANG, Zhao-chu WANG, Min-yuan LU, Rong SHI
Modern Preventive Medicine | 2025, 52(6) : 977 - 982
Less
收藏切换
Modern Preventive Medicine | 2025, 52(6): 977-982
Epidemiology and Statistical Methods Advances
Analysis and prediction of IBD disease burden in China, 1990-2021
Full
Hui-min LIU, Jing WANG, Zhao-chu WANG, Min-yuan LU, Rong SHI
Affiliations
  • Fujian University of Traditional Chinese Medicine, Affiliated People’s Hospital, Fuzhou, Fujian 350004, China
Published: 2025-03-25 doi: 10.20043/j.cnki.MPM.202412217
Outline
收藏切换
Objective

To evaluate the current status and development trends of Inflammatory Bowel Disease (IBD) in China, providing decision support for policy adjustments by government and health departments.

Methods

Data extraction from the 2024 Global Burden of Disease (GBD) database was conducted for indicators related to the incidence, prevalence, mortality, and Disability-Adjusted Life Years (DALYs) of IBD in China. Joinpoint regression analysis was used to calculate the Annual Percent Change (APC) and the Average Annual Percent Change (AAPC). Additionally, an Autoregressive Integrated Moving Average Model (ARIMA) was employed to forecast disease characteristics from 2022 to 2031.

Results

From 1990 to 2021, the number of prevalent cases, incident cases, and deaths from IBD in China, as well as the age-standardized prevalence rate (ASPR), and age-standardized incidence rate (ASIR) showed an upward trend. By 2021, these figures stood at 168077 prevalent cases, 24 941 new cases, and 5 640 deaths, with ASPR and ASIR reaching 9.16 per 100 000 people and 1.4 per 100 000 people, respectively, representing a significant increase compared to 1990 levels. Meanwhile, the age-standardized mortality rate (ASMR) and age-standardized DALY rate (ASDR) exhibited a downward trend, standing at 0.33 per 100 000 people and 7.68 per 100 000 person-years in 2021, with notable differences observed across age groups and genders. The ARIMA model predicted that by 2031, the ASPR, ASIR, ASMR, and ASDR would decrease compared to 2021 levels, projecting figures of 5.23 per 100 000 people, 1.20 per 100 000 people, 0.21 per 100 000 people, and 5.41 per 100 000 person-years, respectively.

Conclusion

Currently, the incidence and prevalence of IBD in China are on the rise. Although this trend may change over the next decade, given China’s large population base and demographic structure, it is essential to strengthen primary and secondary prevention efforts among key populations, particularly males and the elderly.

Inflammatory bowel disease  /  China  /  Health threat  /  Disease burden  /  Predictive analysis
Hui-min LIU, Jing WANG, Zhao-chu WANG, Min-yuan LU, Rong SHI. Analysis and prediction of IBD disease burden in China, 1990-2021[J]. Modern Preventive Medicine, 2025 , 52 (6) : 977 -982 . DOI: 10.20043/j.cnki.MPM.202412217
Year 2025 volume 52 Issue 6
PDF
96
44
Cite this Article
BibTeX
Article Info
doi: 10.20043/j.cnki.MPM.202412217
  • Receive Date:2024-12-12
  • Online Date:2026-03-18
  • Published:2025-03-25
Article Data
Affiliations
History
  • Received:2024-12-12
Funding
Affiliations
    Fujian University of Traditional Chinese Medicine, Affiliated People’s Hospital, Fuzhou, Fujian 350004, China
References
Share
https://castjournals.cast.org.cn/joweb/xdyfyx/EN/10.20043/j.cnki.MPM.202412217
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT